Загрузка...
Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)
PURPOSE OF REVIEW: The aim of low-density lipoprotein-cholesterol (LDL-C) lowering therapies is to safely achieve a consistent and long-term reduction in exposure of the vasculature to atherogenic lipoproteins in order to reduce the risk of atherosclerotic cardiovascular (CV) disease and the associa...
Сохранить в:
| Опубликовано в: : | Curr Cardiol Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578129/ https://ncbi.nlm.nih.gov/pubmed/33089390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11886-020-01427-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|